Novo Nordisk A/S (NVO) Says Obesity Drug Trial Confirms Weight Loss
5/23/2013 11:32:37 AM
More...
|
Zensun Announces Positive Clinical Results for Neucardin™ to Improve Heart Function and Reduce Mortality in Chronic Heart Failure Patients
5/23/2013 9:52:04 AM
More...
|
Opko Health, Inc. Surpasses 50% Enrollment in First Phase 3 Trial of Rayaldy™ (CTAP101 Capsules)
5/23/2013 11:10:03 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Initiates TOURMALINE-MM2 Pivotal Phase 3 Trial of MLN9708 in Patients With Newly Diagnosed Multiple Myeloma
5/23/2013 11:04:43 AM
More...
|
TauRx Therapeutics Release: First UK Patients Enroll in Phase 3 Clinical Trials of LMTX™ for Alzheimer's Disease
5/23/2013 10:05:27 AM
More...
|
Bayer HealthCare (BAY) Says Lung Drug Shows Promise in Prolonged Trial
5/21/2013 7:38:57 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Statistically Significant Results for Budesonide Foam in the Treatment of Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis in Two Pivotal Phase 3 Studies
5/22/2013 11:08:44 AM
More...
|
Upsher-Smith Laboratories Successfully Completes Phase III Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Epilepsy in Patients With Refractory Partial-Onset Seizures
5/22/2013 11:00:42 AM
More...
|
XenoPort, Inc. (XNPT) Drops Multiple Sclerosis Drug After Trial Failure
5/20/2013 8:10:14 AM
More...
|
FDA Staff Says Merck & Co., Inc. (MRK)'s Sleep Drug Effective, Questions Dosage
5/20/2013 8:04:46 AM
More...
|
AcelRx Pharmaceuticals (ACRX) Drug Device Meets Main Goal of Late-Stage Study
5/21/2013 7:10:21 AM
More...
|
AstraZeneca PLC (AZN) Release: Results From Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
5/21/2013 10:57:00 AM
More...
|
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen Research & Development's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
5/21/2013 10:51:40 AM
More...
|
Boehringer Ingelheim Corporation Release: Phase III Results: Tiotropium* Respimat® Effective in Symptomatic Asthma Patients Despite at Least ICS†/LABA‡ Independent of Their Age, Allergic Status, Smoking Status and Bronchodilator Response
5/21/2013 10:04:35 AM
More...
|
Vectura Group plc (VEC.L) Release: New Data Presented at the American Thoracic Society Meeting Highlights Strength of Once-Daily COPD Portfolio in Improving Lung Function, Shortness of Breath and Reducing Rate of Exacerbations
5/21/2013 9:36:19 AM
More...
|
|